| dc.contributor.author |
Gaikwad, Anil Bhanudas |
|
| dc.date.accessioned |
2023-12-20T09:30:07Z |
|
| dc.date.available |
2023-12-20T09:30:07Z |
|
| dc.date.issued |
2017-08 |
|
| dc.identifier.uri |
https://www.sciencedirect.com/science/article/abs/pii/S1734114016302110 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13462 |
|
| dc.description.abstract |
Non-alcoholic fatty liver disease (NAFLD), a chronic metabolic disorder is associated with oxidative stress, inflammation and fibrotic cascades. In this study, we aimed to examine the effects of Esculetin, a well-known anti-oxidant on TGF-β1 mediated liver fibrosis and FoxO1 activity. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Elsevier |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
Esculetin |
en_US |
| dc.subject |
Non-alcoholic fatty liver disease (NAFLD) |
en_US |
| dc.subject |
Liver fibrosis |
en_US |
| dc.subject |
Hepatic fibrosis |
en_US |
| dc.title |
Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway |
en_US |
| dc.type |
Article |
en_US |